Fabino Enterprises Ltd. Stock Analysis 543444.BO

Fabino Enterprises Ltd. engages in the manufacture and trading of pharmaceutical, allopathic, herbal, veterinary, and other wellness focused consumer products. The company is headquartered in Sonipat, Haryana and currently employs 9 full-time employees. The company went IPO on 2022-01-13. The firm is engaged in the manufacturing, marketing, trading and packaging of pharmaceutical and other wellness-focused consumer products. Its core business is the marketing of pharmaceutical formulations and products in the domestic market through its own distribution network and sales force under its own brand name, getting its ayurvedic formulations manufactured through loan licensing facilities, packing, and labeling. The company exports wellness and fast-moving consumer goods (FMCG) products, such as coffee, malt powder, protein powder, hair shampoo, which are marketed by its company. Its products include 21 No Tea, AMOXRAG-625, Astrid Syrup, Aur D3 Capsules, Aurceta AM, Aurcis-Forte, Aurifox OZ, Aurimor Gold, Aurimor plus, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Aurstin 500, Aurzyme-Syrup, Ayush Kadha, Calogrip, Cefga 1gm, Cekal Forte, Ceporag O, Coptec Capsules, Coptec-syrup, Cough-Free, and Dexrog Syrup.